IQ Consortium representatives explore and define common industry approaches and practices for applying GMPs in early development, with a focus on stability.
Tony Mazzeo
Advertisement
Articles by Tony Mazzeo
IQ Consortium representatives explore and define common industry approaches and practices for applying GMPs in early development.
Advertisement
Latest Updated Articles
Early Development GMPs for Stability (Part IV)Published: September 2nd 2012 | Updated:
- GMPs for Small-Molecule Drugs in Early Development (Part I)
Published: June 2nd 2012 | Updated:
Advertisement
Advertisement
Trending on Pharmaceutical Technology
1
UK’s Persistent Failure to Commercialize R&D Threatens Life Sciences: Report
2
BBB-Crossing Tech for Lysosomal Storage Disorders at Center of Chiesi–Aliada Partnership
3
Achieving a Personalized Digital Control Arm for Preclinical Drug Evaluation
4
At AAPS PharmSci 360, Solutions for Challenges in Amorphous Solid Dispersion Development
5
